EP Patent

EP0308181A1 — Trans-mucosal delivery formulations and a method for preparation thereof

Assigned to Novo Nordisk AS · Expires 1989-03-22 · 37y expired

What this patent protects

The systemic absorption after non-enteral, trans­mucosal delivery of certain drugs, in particular pharmacologically active polypeptides, is enhanced from formulations containing a monosaccharide or an oligosaccharide, preferably a cyclodextrin.

USPTO Abstract

The systemic absorption after non-enteral, trans­mucosal delivery of certain drugs, in particular pharmacologically active polypeptides, is enhanced from formulations containing a monosaccharide or an oligosaccharide, preferably a cyclodextrin.

Drugs covered by this patent

Patent Metadata

Patent number
EP0308181A1
Jurisdiction
EP
Classification
—
Expires
1989-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.